Obsidian Therapeutics Inc. has agreed to merge with Galera Therapeutics Inc.
LONDON: RTW Biotech Opportunities Ltd, a London-listed investment company focused on the life sciences sector, said Tuesday that portfolio company Obsidian Therapeutics Inc. has agreed to merge with Galera Therapeutics Inc. in a reverse merger that includes a $350 million…